PubMed HealthSearch

PubMed · 8409323

Hepatic dysfunction after repeated isoflurane administration.

Abstract

Isoflurane, a halogenated volatile anesthetic, has not been associated with a distinct hepatic injury syndrome, as has halothane. Previous cases of suspected isoflurane-induced hepatotoxicity have been reported but questioned. We report the case of a patient without previous liver disease who developed repeated episodes of hepatitis after repeated exposures to isoflurane. Although no biopsy study was conducted, the temporal relationships illustrated in this case strengthen the argument for isoflurane-induced hepatotoxicity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D M Scheider, L M Klygis, T K Tsang, M C Caughron. 1993. Hepatic dysfunction after repeated isoflurane administration.. https://doi.org/10.1097/00004836-199309000-00017

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

ASHP Therapeutic Position Statement on the safe use of niacin in the management of dyslipidemias. American Society of Health-System Pharmacists.

ASHP supports the use of niacin as an effective therapy for the management of dyslipidemias in adults. Successful and safe therapy requires ongoing supervision and instruction by qualified health care providers to monitor the efficacy of therapy and minimize niacin's potential for adverse effects. Because many niacin products are available without a prescription, pharmacists are in a unique position to help ensure that patients make the best use of this medication.

Chemical and Drug Induced Liver Injury